Complosome—the intracellular complement system

EE West, C Kemper - Nature Reviews Nephrology, 2023 - nature.com
The complement system is a recognized pillar of host defence against infection and noxious
self-derived antigens. Complement is traditionally known as a serum-effective system …

Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms

Y Zhu, Y Chai, G **ao, Y Liu, X **e, W **ao… - Frontiers in …, 2022 - frontiersin.org
Fibrosis is the abnormal deposition of extracellular matrix, characterized by accumulation of
collagen and other extracellular matrix components, which causes organ dysfunction and …

CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure

Y Zhang, Y Ye, X Tang, H Wang, T Tanaka… - Journal of Experimental …, 2022 - rupress.org
Circulating proteomic signatures of age are closely associated with aging and age-related
diseases; however, the utility of changes in secreted proteins in identifying therapeutic …

The probiotic Lactobacillus casei Zhang-mediated correction of gut dysbiosis ameliorates peritoneal fibrosis by suppressing macrophage-related inflammation via the …

Z Wu, X Zuo, X Wang, M Shi, H Zhu, C Cao, X Liu… - Food & Function, 2023 - pubs.rsc.org
Peritoneal fibrosis is a complication of long-term peritoneal dialysis (PD) that restricts its
clinical application for the treatment of end-stage renal disease. Lactobacillus casei Zhang …

[HTML][HTML] Pathophysiological mechanisms of peritoneal fibrosis and peritoneal membrane dysfunction in peritoneal dialysis

Y Ito, T Sun, M Tawada, H Kinashi… - International Journal of …, 2024 - mdpi.com
The characteristic feature of chronic peritoneal damage in peritoneal dialysis (PD) is a
decline in ultrafiltration capacity associated with pathological fibrosis and angiogenesis. The …

Novel aspects of the immune response involved in the peritoneal damage in chronic kidney disease patients under dialysis

F Trionfetti, V Marchant, GT González-Mateo… - International Journal of …, 2023 - mdpi.com
Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage
of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney …

Selective activation of PPARα by pemafibrate mitigates peritoneal inflammation and fibrosis through suppression of NLRP3 inflammasome and modulation of …

Y Shinkai, K Sasaki, R Tamura, T Ike, A Takahashi… - Scientific Reports, 2024 - nature.com
Peritoneal inflammation and fibrosis remain major challenges to the long-term maintenance
of peritoneal dialysis. Pemafibrate, a selective peroxisome proliferator-activated receptor α …

Transglutaminases in fibrosis—overview and recent advances

F Soltani, MT Kaartinen - American Journal of Physiology …, 2023 - journals.physiology.org
Transglutaminases (TGs) are a family of protein cross-linking enzymes that are capable of
stiffening and insolubilizing proteins and creating protein networks, and thereby altering …

Current insights into cellular determinants of peritoneal fibrosis in peritoneal dialysis: A narrative review

SD Suryantoro, M Thaha, H Sutanto… - Journal of Clinical …, 2023 - mdpi.com
Peritoneal fibrosis is the final process of progressive changes in the peritoneal membrane
due to chronic inflammation and infection. It is one of the main causes of discontinuation of …

HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells

F Trionfetti, T Alonzi, G Bontempi, M Terri… - Frontiers in Cellular …, 2023 - frontiersin.org
Background Despite the significant progress achieved in understanding the pathology and
clinical management of SARS-CoV-2 infection, still pathogenic and clinical issues need to …